Document Detail

Audiovestibular Dysfunction Associated with Adoptive Cell Immunotherapy for Melanoma.
MedLine Citation:
PMID:  22597578     Owner:  NLM     Status:  Publisher    
Objective. To understand the audiologic and vestibular toxicities associated with adoptive cell immunotherapy (ACI) targeting pigment-pathway antigens on melanoma and to investigate the use of intratympanic steroid injections in the treatment of these toxicities.Study Design. Prospective nonrandomized study.Setting. Tertiary clinical research center.Methods. Thirty-two patients with progressive metastatic melanoma who failed conventional therapy underwent ACI with T cells genetically modified to target MART-1 (n = 18) or gp100 (n = 14). All patients received serial audiometric testing. Vestibular testing was performed on patients with vestibular complaints. Patients with significant deficits received intratympanic steroid injections.Results. Of 32 patients, 15 had no hearing change, 9 had mild hearing loss, and 8 had moderate hearing loss following treatment. Ten patients received intratympanic steroid injections for mild (n = 2) or moderate (n = 7) hearing loss or for significant imbalance (n = 1). Of those with mild hearing loss (n = 9), all but 1 recovered to pretreatment hearing levels. Four of 8 patients with moderate hearing loss recovered to baseline hearing levels, and 4 had partial recovery. All 7 patients with posttreatment vestibular complaints had demonstrable vestibular dysfunction. Three of these patients demonstrated recovery to normal vestibular function. The number of modified T cells infused for therapy correlated with the degree of audiovestibular deficit.Conclusion. Adoptive cell immunotherapy targeting pigment-pathway cell proteins, a novel therapy for melanoma, can induce hearing loss and vestibular dysfunction. The presumed mechanism of autoimmune attack on normal melanocytes in the cochlear stria vascularis and in the vestibular organs demonstrates the importance of melanocytes in normal inner ear function.
Bradley J Seaman; Elizabeth A Guardiani; Carmen C Brewer; Christopher K Zalewski; Kelly A King; Susan Rudy; Carter Van Waes; Richard A Morgan; Mark E Dudley; James C Yang; Steven A Rosenberg; H Jeffrey Kim
Related Documents :
1423558 - The influence of acetazolamide on cerebral low-flow regions in migraine--an interictal ...
14651138 - Restless legs syndrome: diagnosis and treatment.
21705948 - Gastric emptying in patients with autoimmune pancreatitis.
6643018 - Milk protein-free diet for nonseasonal asthma and migraine in lactase-deficient patients.
54228 - Permanent pacemaker implantation in infants, children, and adolescents. long-term follo...
22390098 - Endonasal endoscopic transsphenoidal pituitary surgery for pituitary adenoma: a retrosp...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-17
Journal Detail:
Title:  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery     Volume:  -     ISSN:  1097-6817     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8508176     Medline TA:  Otolaryngol Head Neck Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Otolaryngology-Head and Neck Surgery, Georgetown University Medical Center, Washington, DC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  How Good Is Google?: The Quality of Otolaryngology Information on the Internet.
Next Document:  Preservation of Viscoelastic Properties of Rabbit Vocal Folds after Implantation of Hyaluronic Acid-...